ZEVRA THERAPEUTICS, INC. (ZVRA) Form 8-K Material Events
ZEVRA THERAPEUTICS, INC. (ZVRA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ZVRA
CIK: 1434647
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerAndrew Menendez
Audit LocationOrlando, Florida, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-13 | 2026-10-10 | FORM 4 | 0001434647-26-000075 | View SEC Doc Filr Page |
| 144 | 2026-10-13 | — | 144 Filing | 0001950047-26-010170 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-14 | FORM 4 | 0001434647-26-000073 | View SEC Doc Filr Page |
| 144 | 2026-08-14 | — | 144 Filing | 0001950047-26-008134 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000919574-26-005266 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | FORM 4 | 0001434647-26-000070 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-002197 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001434647-26-000068 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001434647-26-000067 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-31 | — | SCHEDULE 13G Filing | 0002100119-26-001518 | View SEC Doc Filr Page |
| 144 | 2026-07-08 | — | 144 Filing | 0001950047-26-006950 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-21 | FORM 4 | 0001434647-26-000057 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-04 | FORM 4 | 0001434647-26-000055 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-04 | FORM 4 | 0001434647-26-000054 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-04 | FORM 4 | 0001434647-26-000053 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-04 | FORM 4 | 0001434647-26-000052 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-04 | FORM 4 | 0001434647-26-000051 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-04 | FORM 4 | 0001434647-26-000050 | View SEC Doc Filr Page |
| 8-K | 2026-06-05 | 2026-06-04 | 8-K | 0001434647-26-000041 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-28 | FORM 4 | 0001434647-26-000037 | View SEC Doc Filr Page |
| 4 | 2026-05-13 | 2026-05-11 | FORM 4 | 0001434647-26-000034 | View SEC Doc Filr Page |
| 144 | 2026-05-11 | — | 144 Filing | 0001950047-26-004326 | View SEC Doc Filr Page |
| 10-Q | 2026-05-06 | 2026-03-31 | 10-Q | 0001434647-26-000031 | View SEC Doc Filr Page |
| 8-K | 2026-05-06 | 2026-05-06 | 8-K | 0001434647-26-000029 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-06 | — | SCHEDULE 13G Filing | 0000315066-26-001339 | View SEC Doc Filr Page |